Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01785966
Other study ID # 11673812310010060
Secondary ID
Status Completed
Phase N/A
First received February 1, 2013
Last updated March 2, 2015
Start date August 2013
Est. completion date November 2014

Study information

Verified date November 2014
Source Hospital do Coracao
Contact n/a
Is FDA regulated No
Health authority Brazil: National Health Surveillance Agency
Study type Interventional

Clinical Trial Summary

CHECKLIST-ICU will be a cluster randomized trial to ascertain whether the use of an intervention including 1) checklists with assessment of daily goals during the multidisciplinary visit, and 2) clinician prompting can reduce in-hospital mortality of patients admitted to intensive care units (ICUs).

The investigators also aim to describe participant ICUs in terms of the standards for intensive care units proposed by the Brazilian National Health Agency (ANVISA).


Description:

Cluster randomized trial involving ICUs in Brazil. ICU is the unit of randomization.

The trial will have two stages:

- Stage I - Baseline data.In this stage we will:

- Apply "Safety Attitudes Questionnaire" for the employees of the participating ICU.

- Characterize participant ICUs in terms of the standards (RDC nº7/2010, RDC nº26/2012 e RDC nº 63/2011) for intensive care units proposed by the Brazilian National Health Agency (ANVISA)

- Characterize patients: we will collect data from 60 consecutive critically ill patients from each participant ICU to describe adherence to measures aimed at avoiding ICU complications and clinical outcome measures.

- Stage II - Intervention: This is the main stage for data analysis. ICUs will be randomly assigned to an experimental or control group. The experimental group should use a multi-item verbal checklist including assessment of daily goals during the multidisciplinary visits plus clinician prompting. We will collect data from 60 additional patients for each ICU in both study groups and apply "Safety Attitudes Questionnaire".


Recruitment information / eligibility

Status Completed
Enrollment 13637
Est. completion date November 2014
Est. primary completion date November 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion criteria for clusters:

- Intensive care units, except dedicated coronary care units/cardiac intensive care units and step-down units;

- Must have multidisciplinary daily rounds or coordinators agree to implement daily rounds, including at least one physician and one nurse, conducted at least on week days.

Exclusion criteria for clusters:

• We will exclude ICUs that systematically apply checklists in the multiprofessional daily visit. We define systematically applied checklist when all the following criteria are met:

- Content: structured evaluation following a digital or printed document of multiple items focused on prevention of common ICU complications (eg. ventilator-associated pneumonia, stress ulcer, venous thromboembolism and/or catheter-associated bloodstream infection) and/or explicit assessment of daily goals;

- Time frame: daily application of checklist for at least 30 days

- Periodicity: at least 3 days per week

- How is applied: verbal, observational (1 professional check all items), with or without written register

Patient inclusion criteria:

• Adult patients (=18 years-old) with anticipated ICU length of stay > 24 hours.

Patient exclusion criteria;

- High probability of death within 24 hours or patients admitted in ICU for palliative care only;

- Suspected or confirmed brain death.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label


Related Conditions & MeSH terms


Intervention

Behavioral:
Daily checklist and clinician prompting
Interventions are: Checklists: The checklists are arranged in a paper notebook (one per patient) with a daily list on each page, as most ICUs do not have electronic health record systems. During the multidisciplinary visit, the checklist items are read aloud by the nurse and answered by participants of the visit. The checklist is applied at least once on all week days preferably in the mornings, although we strongly suggest applying it also on weekend days. Daily Goals and Clinician Prompting: During the clinical discussion of each patient and the application of the checklist, the intensivists write down the daily goals in a standardized form and read them aloud to the team. Every afternoon between 3 and 5 PM, a nurse reviews the daily goals and takes note of any pending items. Subsequently, the nurse prompts the on-call physician, requesting solutions for these pending items.

Locations

Country Name City State
Brazil Alexandre Biasi Cavalcanti São Paulo SP

Sponsors (3)

Lead Sponsor Collaborator
Hospital do Coracao D'Or Institute for Research and Education, Sociedade Hospital Samaritano

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary In-hospital mortality truncated at 60 days Follow-up will be limited to 60 days after ICU admission. Patients who are still in the hospital after 60 days of ICU admission will be considered as discharged alive. Hospital discharge; average of 20 days; follow-up limited to 60 days No
Secondary Head of the bed elevated at 30° Every 3 three days, from ICU day 2 to 17 No
Secondary Adequate prophylaxis for venous thromboembolism Every 3 three days, from ICU day 2 to 17 No
Secondary Patient-days under light sedation or alert and calm (RASS - 3 to 0) Every 3 three days, from ICU day 2 to 17 No
Secondary Rate of central-line catheter use Daily from ICU day 2 to 17 No
Secondary Indwelling urinary catheter use rate Daily from ICU day 2 to 17 No
Secondary Rate of patients receiving enteral or parenteral feeding Every 3 three days, from ICU day 2 to 17 No
Secondary Tidal volume <=8mL/kg of predicted body weight in patients on mechanical Every 3 three days, from ICU day 2 to 17 No
Secondary ICU mortality Follow-up will be limited to 60 days after ICU admission. Patients who are still in the ICU after 60 days of ICU admission will be considered as discharged alive. ICU discharge; follow-up limited to 60 days No
Secondary Central line-associated bloodstream infection (CLABSI) rate Following the Centers for Disease Control/National Healthcare Safety Network (CDC/NHSN) Surveillance Definition of Healthcare-Associated Infection 2008 Daily from ICU day 2 to 17 No
Secondary Urinary tract infection associated with catheter rate Daily from ICU day 2 to 17 No
Secondary Ventilator-associated pneumonia (VAP) Daily from ICU day 2 to 17 No
Secondary Length of ICU stay Follow-up will be limited to 60 days after ICU admission. Patients who are still in the hospital after 60 days of ICU admission will be considered as discharged alive. Hospital discharge; follow-up limited to 60 days No
Secondary Length of hospital stay Follow-up will be limited to 60 days after ICU admission. Patients who are still in the hospital after 60 days of ICU admission will be considered as discharged alive. Hospital discharge; average of 20 days; follow-up limited to 60 days No
Secondary Mechanical ventilation-free days at 28 days Survival time free of invasive mechanical ventilation from ICU admission to day 28.
Patients who were discharged from hospital alive before 28 days are considered to be alive and free of mechanical ventilation until the 28th day.
Day 28 after ICU admission No
Secondary Safety Attitudes Questionnaire Score Survey In phase 1, between sept/2013 and january/2014 each ICU staff answered the questionnaire once. In phase 2, between july/2014 and december/2014 the questionnaire was applied again (once for each ICU staff). No
See also
  Status Clinical Trial Phase
Recruiting NCT05114551 - ICU Predictive Score of WEaning Success in Patients At Risk of Extubation Failure
Completed NCT05547646 - The Prevalence of Healthcare-associated Infection in Medical Intensive Care Units in Tunisia
Recruiting NCT03697785 - Weaning Algorithm for Mechanical VEntilation N/A
Completed NCT02922101 - Evaluation of the Effectiveness of an Audit and Feedback Intervention With Quality Improvement Toolbox in Intensive Care N/A
Completed NCT02902783 - DONATE-Pilot Study on ICU Management of Deceased Organ Donors
Completed NCT01857986 - Evaluating Air Leak Detection in Intubated Patients N/A
Completed NCT01885442 - TryCYCLE: A Pilot Study of Early In-bed Leg Cycle Ergometry in Mechanically Ventilated Patients N/A
Recruiting NCT05518955 - VR Integrated Into Multicomponent Interventions for Improving Sleep in ICU N/A
Recruiting NCT03810768 - Metabolomics Study on Postoperative Intensive Care Acquired Muscle Weakness
Completed NCT03295630 - Validity of an Actigraph Accelerometer Following Critical Illness N/A
Completed NCT05556811 - HEaling LIght Algorithms for the ICU Patient N/A
Recruiting NCT05702411 - Air Stacking Technique For Pulmonary Reexpansion N/A
Completed NCT02741453 - Bilateral Internal Jugular Veins Ultrasound Scanning Prior to CVC Placement N/A
Recruiting NCT04979897 - Impact on Mental, Physical, And Cognitive Functioning of a Critical Care sTay During the COVID-19 Pandemic
Completed NCT05281224 - Ventilator Tube Holder for Patients With a Tracheostomy
Withdrawn NCT02970903 - VitalPAD: an Intelligent Monitoring and Communication Device to Optimize Safety in the PICU N/A
Recruiting NCT02587273 - The Pharmacokinetics of Fentanyl in Intensive Care Patients Phase 4
Completed NCT02661607 - Point of Care Echocardiography Versus Chest Radiography for the Assessment of Central Venous Catheter Placement N/A
Completed NCT01479153 - Venous Site for Central Catheterization N/A
Recruiting NCT06110390 - High-flow Nasal Oxygen Therapy to Prevent Extubation Failure in Adult Trauma Intensive Care Patients N/A